Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19.
Algorithms
CD3 Complex
/ genetics
CD4 Antigens
/ genetics
COVID-19
/ epidemiology
Chemokine CXCL10
/ genetics
Computational Biology
Cyclophilin A
/ genetics
Cyclosporine
/ pharmacology
Databases, Genetic
Genome-Wide Association Study
Genomics
Humans
Immune System
Immunogenetics
Inflammation
Interleukin-1alpha
/ genetics
Microtubule-Associated Proteins
/ genetics
Proteomics
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 12 2020
18 12 2020
Historique:
received:
24
09
2020
accepted:
02
12
2020
entrez:
19
12
2020
pubmed:
20
12
2020
medline:
5
1
2021
Statut:
epublish
Résumé
The increasing body of literature describing the role of host factors in COVID-19 pathogenesis demonstrates the need to combine diverse, multi-omic data to evaluate and substantiate the most robust evidence and inform development of therapies. Here we present a dynamic ranking of host genes implicated in human betacoronavirus infection (SARS-CoV-2, SARS-CoV, MERS-CoV, seasonal coronaviruses). We conducted an extensive systematic review of experiments identifying potential host factors. Gene lists from diverse sources were integrated using Meta-Analysis by Information Content (MAIC). This previously described algorithm uses data-driven gene list weightings to produce a comprehensive ranked list of implicated host genes. From 32 datasets, the top ranked gene was PPIA, encoding cyclophilin A, a druggable target using cyclosporine. Other highly-ranked genes included proposed prognostic factors (CXCL10, CD4, CD3E) and investigational therapeutic targets (IL1A) for COVID-19. Gene rankings also inform the interpretation of COVID-19 GWAS results, implicating FYCO1 over other nearby genes in a disease-associated locus on chromosome 3. Researchers can search and review the gene rankings and the contribution of different experimental methods to gene rank at https://baillielab.net/maic/covid19 . As new data are published we will regularly update the list of genes as a resource to inform and prioritise future studies.
Identifiants
pubmed: 33339864
doi: 10.1038/s41598-020-79033-3
pii: 10.1038/s41598-020-79033-3
pmc: PMC7749145
doi:
Substances chimiques
CD3 Complex
0
CD3E protein, human
0
CD4 Antigens
0
CXCL10 protein, human
0
Chemokine CXCL10
0
FYCO1 protein, human
0
IL1A protein, human
0
Interleukin-1alpha
0
Microtubule-Associated Proteins
0
Cyclosporine
83HN0GTJ6D
Cyclophilin A
EC 5.2.1.-
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
22303Subventions
Organisme : Medical Research Council
ID : MC_PC_19025
Pays : United Kingdom
Références
Clin Microbiol Rev. 2008 Jan;21(1):13-25
pubmed: 18202435
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Viruses. 2021 Apr 09;13(4):
pubmed: 33918958
Nat Commun. 2018 Sep 6;9(1):3603
pubmed: 30190477
J Virol. 2021 Jan 13;95(3):
pubmed: 33177207
Pharmacol Ther. 2020 Sep;213:107587
pubmed: 32470470
PLoS Pathog. 2009 Aug;5(8):e1000546
pubmed: 19680534
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Cell Death Dis. 2013 Oct 31;4:e888
pubmed: 24176846
Gastroenterology. 2005 Sep;129(3):1031-41
pubmed: 16143140
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Nat Microbiol. 2020 Nov;5(11):1330-1339
pubmed: 32704094
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
PLoS One. 2015 Aug 11;10(8):e0134707
pubmed: 26263487
Hum Genomics. 2020 Sep 11;14(1):30
pubmed: 32917282
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Immunol Res. 2020 Jun;68(3):161-168
pubmed: 32524333
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201
pubmed: 33217246
Inflamm Res. 2008 Nov;57(11):519-23
pubmed: 19109744
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Hepatology. 2003 Nov;38(5):1282-8
pubmed: 14578868
Nucleic Acids Res. 2016 Jan 4;44(D1):D7-19
pubmed: 26615191
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Cytokine Growth Factor Rev. 2011 Jun;22(3):121-30
pubmed: 21802343
PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Bioinformatics. 2012 Feb 15;28(4):573-80
pubmed: 22247279
PLoS One. 2012;7(2):e31063
pubmed: 22347431
Cytokine. 2021 Jan;137:155302
pubmed: 33002740
J Virol. 2015 Apr;89(8):4434-48
pubmed: 25653449
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
Science. 2014 May 23;344(6186):807-8
pubmed: 24855243
Hepatology. 2009 May;49(5):1460-8
pubmed: 19353740
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
J Gastroenterol. 2003;38(6):567-72
pubmed: 12825133
Nat Commun. 2020 Jan 9;11(1):164
pubmed: 31919360
Sci Rep. 2017 Mar 28;7(1):483
pubmed: 28352119
Sci Rep. 2015 Nov 03;5:16119
pubmed: 26524966
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Viruses. 2011 Sep;3(9):1610-23
pubmed: 21994798
PLoS Pathog. 2011 Oct;7(10):e1002331
pubmed: 22046132
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Immunol. 2018 Jun;19(6):625-635
pubmed: 29777224
J Intensive Care. 2020 May 24;8:36
pubmed: 32483488
Lancet Rheumatol. 2020 Aug;2(8):e465-e473
pubmed: 32835256
medRxiv. 2020 May 06;:
pubmed: 32511488
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2
pubmed: 32359396
J Infect. 2013 Jul;67(1):84-5
pubmed: 23396219
J Virol. 2008 Sep;82(17):8887-90
pubmed: 18562523
Ann Rheum Dis. 2018 Jun;77(6):840-847
pubmed: 29472362
Front Microbiol. 2020 Nov 25;11:593857
pubmed: 33324374
Antimicrob Agents Chemother. 2008 Apr;52(4):1302-17
pubmed: 18212100
Lancet Rheumatol. 2020 Jun;2(6):e325-e331
pubmed: 32501454
PLoS One. 2012;7(5):e37277
pubmed: 22615963